David R. Epstein
Director, International Flavors & Fragrances.
Companies
- AgomAb Therapeutics NVBoard member Mar 18, 2026 to now1
- Tempus AIBoard member Jun 13, 2024 to now2
- SeagenBoard member Nov 10, 2022 to Dec 15, 20233
- SeagenChief executive officer Nov 10, 2022 to Dec 15, 20233
- Senti Biosciences Holdings, Inc.Board member May 25, 2021 to Jul 15, 20224
- Evelo Biosciences, Inc.Board member May 8, 2018 to Jun 30, 20225
- Axcella Health (United States)Board member May 8, 2019 to Jun 3, 20226
- Rubius Therapeutics (United States)Board member Jul 17, 2018 to May 13, 20227
- Opy Acquisition Corp. IBoard member Oct 26, 2021 to Oct 26, 20218
- International Flavors & FragrancesBoard member Jan 11, 2016 to Nov 4, 20209
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Tempus AI TEM30,844 shares10$2.0M at $64.80Sep 1, 2026- Senti Biosciences Holdings, Inc. SNTI123,252 shares11$27.4K at $0.22Jun 8, 2022
Seagen SGEN0 shares12Dec 14, 2023Axcella Health (United States)209,756 shares13May 19, 2022
- Evelo Biosciences, Inc.93,932 shares14Jun 30, 2022
Rubius Therapeutics (United States)4,720,012 shares15Apr 21, 2022- Opy Acquisition Corp. I0 shares16Oct 26, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Sold 250 shares at $65.55 of Tempus AI10
- Aug 3, 2026Sold 370 shares at $43.40 of Tempus AI17
- Jun 1, 2026Sold 250 shares at $49.40 of Tempus AI18
- May 21, 2026Granted 5,913 shares of Tempus AI19
- Mar 2, 2026Sold 250 shares at $50.69 of Tempus AI20
- Feb 2, 2026Sold 370 shares at $59.41 of Tempus AI21
- Dec 1, 2025Sold 250 shares at $75.55 of Tempus AI22
- Nov 3, 2025Sold 370 shares at $90.00 of Tempus AI23
- Sep 2, 2025Sold 250 shares at $73.64 of Tempus AI24
- Aug 1, 2025Sold 370 shares at $55.16 of Tempus AI25
- Jun 2, 2025Sold 250 shares at $55.20 of Tempus AI26
- May 20, 2025Granted 1,997 shares of Tempus AI27
- May 1, 2025Sold 370 shares at $53.50 of Tempus AI28
- Mar 17, 2025Sold 990 shares at $46.83 of Tempus AI29
- Mar 3, 2025Sold 250 shares at $57.52 of Tempus AI30
- Feb 3, 2025Sold 370 shares at $53.31 of Tempus AI31
- Dec 11, 2024Sold 620 shares at $41.81 of Tempus AI32
- Jun 13, 2024Granted 28,514 shares of Tempus AI33
- Dec 14, 2023Returned to company 16,407 shares at $229.00 of Seagen12
- Nov 10, 2023Sold 10,620 shares at $213.01 of Seagen34
- Aug 15, 2023Granted 39,650 shares of Seagen35
- Nov 9, 2022Granted 107,389 shares of Seagen36
- Jun 30, 2022Exercised options 2,874 shares of Evelo Biosciences, Inc.14
- Jun 30, 2022Exercised options 2,053 shares of Evelo Biosciences, Inc.14
- Jun 8, 2022Granted 112,519 shares of Senti Biosciences Holdings, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAgomAb Therapeutics NV, Board member
- 2SEC EDGARTempus AI, Board member
- 3SEC EDGARSeagen, Board member
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARForm 4 filed Aug 5, 2026
- 18SEC EDGARForm 4 filed Jun 3, 2026
- 19SEC EDGARForm 4 filed May 26, 2026
- 20SEC EDGARForm 4 filed Mar 4, 2026
- 21SEC EDGARForm 4 filed Feb 4, 2026
- 22SEC EDGARForm 4 filed Dec 3, 2025
- 23SEC EDGARForm 4 filed Nov 5, 2025
- 24SEC EDGARForm 4 filed Sep 4, 2025
- 25SEC EDGARForm 4 filed Aug 5, 2025
- 26SEC EDGARForm 4 filed Jun 4, 2025
- 27SEC EDGARForm 4 filed May 22, 2025
- 28SEC EDGARForm 4 filed May 5, 2025
- 29SEC EDGARForm 4 filed Mar 19, 2025
- 30SEC EDGARForm 4 filed Mar 5, 2025
- 31SEC EDGARForm 4 filed Feb 5, 2025
- 32SEC EDGARForm 4 filed Dec 13, 2024
- 33SEC EDGARForm 4 filed Jun 17, 2024
- 34SEC EDGARForm 4 filed Nov 13, 2023
- 35SEC EDGARForm 4 filed Aug 17, 2023
- 36SEC EDGARForm 4 filed Nov 14, 2022